Mallinckrodt Plc (MNK) - Financial and Strategic SWOT Analysis Review

  • ID: 4278971
  • SWOT Analysis
  • 55 pages
  • GlobalData
  • Mallinckrodt Pharmaceuticals Plc.
1 of 5

FEATURED COMPANIES

  • Bayer AG
  • Eli Lilly and Company
  • Johnson Matthey Plc
  • Merck & Co Inc
  • Mylan NV
  • Synthomer plc
  • MORE
Mallinckrodt Plc (MNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief Summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Mallinckrodt Plc (Mallinckrodt) is a healthcare products provider that offers generics and active pharmaceutical ingredients. The company offers generic products which include addiction treatment products, compounding powders, unit dose products and resource tool kits. Its active pharmaceutical ingredients comprise acetaminophen and paracetamol; controlled substances and stearates. Mallinckrodt offers nuclear imaging; contrast media and other medical imaging devices. The company also offers contrast media and devices which include advanced integrated softwares, imaging systems, prefilled syringes and others. It markets its products in the UK and abroad. Mallinckrodt is headquartered in Surrey, the UK.

Mallinckrodt Plc Key Recent Developments

Jul 11,2017: Mallinckrodt Finalizes Previously Announced Agreement with DEA and USAOs
May 08,2017: Mallinckrodt Reports Earnings Results for First Quarter of Fiscal 2017
Feb 07,2017: Mallinckrodt Reports Transition Period Results and Announces 2017 Guidance
Nov 29,2016: Mallinckrodt Reports Fiscal 2016 Fourth Quarter and Full-Year Results
Oct 27,2016: Mallinckrodt Builds UK Presence with New Global Corporate Headquarters in Staines-upon-Thames

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bayer AG
  • Eli Lilly and Company
  • Johnson Matthey Plc
  • Merck & Co Inc
  • Mylan NV
  • Synthomer plc
  • MORE
Section 1 - About the Company
Mallinckrodt Plc - Key Facts
Mallinckrodt Plc - Key Employees
Mallinckrodt Plc - Key Employee Biographies
Mallinckrodt Plc - Major Products and Services
Mallinckrodt Plc - History
Mallinckrodt Plc - Company Statement
Mallinckrodt Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis
Mallinckrodt Plc - Business Description
Mallinckrodt Plc - Corporate Strategy
Mallinckrodt Plc - SWOT Analysis
SWOT Analysis - Overview
Mallinckrodt Plc - Strengths
Mallinckrodt Plc - Weaknesses
Mallinckrodt Plc - Opportunities
Mallinckrodt Plc - Threats
Mallinckrodt Plc - Key Competitors

Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
Mallinckrodt Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Mallinckrodt Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Mallinckrodt Plc, Recent Deals Summary

Section 5 - Company’s Recent Developments
Jul 11, 2017: Mallinckrodt Finalizes Previously Announced Agreement with DEA and USAOs
May 08, 2017: Mallinckrodt Reports Earnings Results for First Quarter of Fiscal 2017
Feb 07, 2017: Mallinckrodt Reports Transition Period Results and Announces 2017 Guidance
Nov 29, 2016: Mallinckrodt Reports Fiscal 2016 Fourth Quarter and Full-Year Results
Aug 18, 2016: Mallinckrodt Locates Growing Specialty Brands Businesses In Bedminster, N.J.; Continues Significant St. Louis Reinvestment
May 23, 2016: Mallinckrodt Donates 250,000 Drug Deactivation Systems to ACT Missouri to Support Fight Against Prescription Drug Abuse
May 18, 2016: Mallinckrodt to Change Fiscal Year
May 03, 2016: Mallinckrodt Reports Fiscal 2016 Second Quarter Results
Feb 02, 2016: Mallinckrodt Reports Fiscal 2016 First Quarter Results

Section 6 - Appendix
Methodology
Ratio Definitions
About
Contact
Disclaimer

List of Tables
Mallinckrodt Plc, Key Facts
Mallinckrodt Plc, Key Employees
Mallinckrodt Plc, Key Employee Biographies
Mallinckrodt Plc, Major Products and Services
Mallinckrodt Plc, History
Mallinckrodt Plc, Other Locations
Mallinckrodt Plc, Subsidiaries
Mallinckrodt Plc, Key Competitors
Mallinckrodt Plc, Ratios based on current share price
Mallinckrodt Plc, Annual Ratios
Mallinckrodt Plc, Annual Ratios (Cont...1)
Mallinckrodt Plc, Annual Ratios (Cont...2)
Mallinckrodt Plc, Interim Ratios
Mallinckrodt Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Mallinckrodt Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Mallinckrodt Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Mallinckrodt Plc, Performance Chart (2012 - 2016)
Mallinckrodt Plc, Ratio Charts
Mallinckrodt Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Mallinckrodt Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Synthomer plc
  • Mylan NV
  • Merck & Co Inc
  • Johnson Matthey Plc
  • Eli Lilly and Company
  • Bayer AG
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll